Serina Therapeutics, Inc. (SER)

Serina Therapeutics Statistics

Total Valuation

SER has a market cap or net worth of $52.43 million. The enterprise value is $48.57 million.

Market Cap	52.43M
Enterprise Value	48.57M

Important Dates

The next estimated earnings date is Tuesday, August 19, 2025, after market close.

Earnings Date	Aug 19, 2025
Ex-Dividend Date	n/a

Share Statistics

SER has 9.97 million shares outstanding. The number of shares has increased by 280.66% in one year.

Current Share Class	9.97M
Shares Outstanding	9.97M
Shares Change (YoY)	+280.66%
Shares Change (QoQ)	+7.04%
Owned by Insiders (%)	30.08%
Owned by Institutions (%)	5.71%
Float	2.79M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1,028.01
Forward PS	n/a
PB Ratio	30.71
P/TBV Ratio	30.82
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	952.42
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.45, with a Debt / Equity ratio of 0.26.

Current Ratio	2.45
Quick Ratio	1.81
Debt / Equity	0.26
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-56.20

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-135.82%
Return on Invested Capital (ROIC)	-273.14%
Return on Capital Employed (ROCE)	-436.38%
Revenue Per Employee	$3,923
Profits Per Employee	-$72,231
Employee Count	13
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -34.66% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-34.66%
50-Day Moving Average	5.70
200-Day Moving Average	5.36
Relative Strength Index (RSI)	44.65
Average Volume (20 Days)	37,580

Short Selling Information

The latest short interest is 38,775, so 0.39% of the outstanding shares have been sold short.

Short Interest	38,775
Short Previous Month	28,877
Short % of Shares Out	0.39%
Short % of Float	1.39%
Short Ratio (days to cover)	1.75

Income Statement

In the last 12 months, SER had revenue of $51,000 and -$939,000 in losses. Loss per share was -$0.10.

Revenue	51,000
Gross Profit	-9.27M
Operating Income	-19.11M
Pretax Income	-890,146
Net Income	-939,000
EBITDA	-18.92M
EBIT	-19.11M
Loss Per Share	-$0.10

Balance Sheet

The company has $4.27 million in cash and $412,000 in debt, giving a net cash position of $3.86 million or $0.39 per share.

Cash & Cash Equivalents	4.27M
Total Debt	412,000
Net Cash	3.86M
Net Cash Per Share	$0.39
Equity (Book Value)	1.56M
Book Value Per Share	0.17
Working Capital	3.40M

Cash Flow

In the last 12 months, operating cash flow was -$19.88 million and capital expenditures -$8,000, giving a free cash flow of -$19.89 million.

Operating Cash Flow	-19.88M
Capital Expenditures	-8,000
Free Cash Flow	-19.89M
FCF Per Share	-$2.00

Margins

Gross Margin	n/a
Operating Margin	-37,468.63%
Pretax Margin	-1,988.24%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SER does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-280.66%
Shareholder Yield	-280.66%
Earnings Yield	-1.79%
FCF Yield	-37.94%

Analyst Forecast

The average price target for SER is $13.00, which is 147.15% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.00
Price Target Difference	147.15%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SER has an Altman Z-Score of -11.67 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-11.67
Piotroski F-Score	1